TherapeuticsMD (TXMD) Inventory (2010 - 2022)

TherapeuticsMD's Inventory history runs 13 years deep, the most recent figure standing at $6.7 million for Q3 2022.

• Quarterly Inventory fell 8.98% year-over-year to $6.7 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $6.7 million (down 8.98% YoY) and the FY2021 annual result came in at $7.6 million, down 4.64% from the prior year.
• Inventory was $6.7 million for Q3 2022 at TherapeuticsMD, up from $6.1 million in the prior quarter.
• Across five years, Inventory topped out at $14.6 million in Q1 2020 and bottomed at $1.6 million in Q1 2018.
• A 5-year average of $7.3 million and a median of $7.5 million in 2019 frame the typical range for Inventory.
• Annual changes were most pronounced in 2019 — Inventory surged 342.89% — and 2021, when it slumped 49.71%.
• TherapeuticsMD's Inventory stood at $3.3 million in 2018, then jumped by 262.97% to $11.9 million in 2019, then plunged by 32.61% to $8.0 million in 2020, then fell by 4.64% to $7.6 million in 2021, then fell by 12.08% to $6.7 million in 2022.
• Business Quant data shows TXMD's Inventory at $6.7 million in Q3 2022, $6.1 million in Q2 2022, and $9.0 million in Q1 2022.